We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > colchicine

News List

Gout Drug Colchicine Won't Help Fight COVID-19 Drugs
November 26, 2021
Add an inexpensive gout drug to the growing list of medications touted as potential COVID-19 treatments -- only to offer no apparent benefit.
CSIR, Laxai Life Sciences get DCGI nod for clinical trials of Colchicine on COVID-19 patients expresspharma
June 15, 2021
Enrolment of patients has already begun at multiple sites across India and the trial is likely to be completed in the next 8-10 weeks.
Colchicine added to UK’s COVID-19 ‘RECOVERY’ trial pharmatimes
December 01, 2020
Commonly used anti-inflammatory drug colchicine is set to be investigated in the UK’s RECOVERY trial, which is testing treatments for patients hospitalised with COVID-19.